NO990909D0 - Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA - Google Patents

Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA

Info

Publication number
NO990909D0
NO990909D0 NO990909A NO990909A NO990909D0 NO 990909 D0 NO990909 D0 NO 990909D0 NO 990909 A NO990909 A NO 990909A NO 990909 A NO990909 A NO 990909A NO 990909 D0 NO990909 D0 NO 990909D0
Authority
NO
Norway
Prior art keywords
edta
composition containing
disodium salt
surface composition
lornoxicam
Prior art date
Application number
NO990909A
Other languages
English (en)
Other versions
NO326350B1 (no
NO990909L (no
Inventor
Hermann Ruckendorfer
Philippus Egger
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Publication of NO990909D0 publication Critical patent/NO990909D0/no
Publication of NO990909L publication Critical patent/NO990909L/no
Publication of NO326350B1 publication Critical patent/NO326350B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19990909A 1996-09-03 1999-02-25 Farmasoytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA NO326350B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0156496A ATA156496A (de) 1996-09-03 1996-09-03 Pharmazeutische zusammensetzung
PCT/EP1997/004742 WO1998009654A1 (de) 1996-09-03 1997-09-01 Pharmazeutische zusammensetzung enthaltend lornoxicam und ein dinatriumsalz der edta

Publications (3)

Publication Number Publication Date
NO990909D0 true NO990909D0 (no) 1999-02-25
NO990909L NO990909L (no) 1999-02-25
NO326350B1 NO326350B1 (no) 2008-11-17

Family

ID=3516134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990909A NO326350B1 (no) 1996-09-03 1999-02-25 Farmasoytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA

Country Status (12)

Country Link
EP (1) EP0934079B1 (no)
JP (1) JP4122062B2 (no)
CN (1) CN1108822C (no)
AT (2) ATA156496A (no)
AU (1) AU4552597A (no)
CA (1) CA2264626C (no)
DE (1) DE59706450D1 (no)
DK (1) DK0934079T3 (no)
ES (1) ES2172002T3 (no)
NO (1) NO326350B1 (no)
PT (1) PT934079E (no)
WO (1) WO1998009654A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172183A (ja) * 1999-12-21 2001-06-26 Wakamoto Pharmaceut Co Ltd 眼科用医薬組成物
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
IN2012DN03157A (no) 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012127496A1 (en) 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
CN106727364B (zh) * 2016-12-02 2020-01-24 苏州天马医药集团天吉生物制药有限公司 一种注射用氯诺昔康的冻干工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203703B (it) * 1983-05-23 1989-02-15 Bruschettin Srl Composizione farmaceutica a carattere di collirio ad azione antiinfiammatoria,e procedimento per la sua preparazione
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
WO1996041646A2 (en) * 1995-06-13 1996-12-27 Dyer, Alison, Margaret Pharmaceutical compositions containing lornoxicam and cyclodextrin

Also Published As

Publication number Publication date
CN1228710A (zh) 1999-09-15
CA2264626C (en) 2009-03-24
JP4122062B2 (ja) 2008-07-23
CN1108822C (zh) 2003-05-21
EP0934079B1 (de) 2002-02-20
EP0934079A1 (de) 1999-08-11
NO326350B1 (no) 2008-11-17
AU4552597A (en) 1998-03-26
CA2264626A1 (en) 1998-03-12
JP2000517331A (ja) 2000-12-26
NO990909L (no) 1999-02-25
WO1998009654A1 (de) 1998-03-12
PT934079E (pt) 2002-06-28
ES2172002T3 (es) 2002-09-16
ATE213420T1 (de) 2002-03-15
DK0934079T3 (da) 2002-04-02
DE59706450D1 (de) 2002-03-28
ATA156496A (de) 1997-10-15

Similar Documents

Publication Publication Date Title
EE9800187A (et) Trombiini inhibiitorite eelravimid
NO965327D0 (no) Sporbare brönnsementsammensetninger og metoder
LV12102A (lv) Rotamazes funkciju inhibitori
BR9607791A (pt) Formulação oral de 2-metil-tieno-benzodiazepina
DE69412842T2 (de) Endodontisches instrument vorbestimmter flexibilität
DK0850004T3 (da) Tandbørste og fremgangsmåde til fremstilling af en sådan
PL322904A1 (en) Sulphonamidic inhibitors of aspartil protease containing oxidated heterocyclic group
NO974495D0 (no) Forbindelse og sammensetninger for levering av aktive midler
PL322877A1 (en) Sulphonamidic inhibitors of aspartil hiv protease containing thf
NO954056L (no) Kombinasjon av laser tracker og kamerabasert koordinatmåling
NO990909D0 (no) Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA
MX9205725A (es) Formulaciones generantes de gas no azidico
DK42093D0 (da) Administrationsmetode
DK516487A (da) Laegemiddel indholdende en kombination af angiotensin-converting-enzyme-inhibitorer og calciumantagonister
IS1821B (is) Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs
HUP9904065A2 (hu) Olanzapint tartalmazó bevonatos gyógyszerkészítmények
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
NO20054619D0 (no) Sammensetninger og fremgangsmater for behandling av underjordiske formasjoner
ID22716A (id) Peneboran benda benda padat lembut yang diberi bentuk
IT1276799B1 (it) Formulazioni di f-silicone
NO924528L (no) Derivater av humant gallesalt-stimulert lipase og farmasoeytiske sammensetninger som inneholder disse
FI973500A (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
DE69631339D1 (de) Verwaltung kryptographischer schlüssel
KR960031694U (ko) 콘크리트로 만든 폼타이용 콘-넛트
NO953272L (no) Kombinasjoner av retrovirale inhibitorer

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA PHARMA A/S, DK

MK1K Patent expired